Tectonic Therapeutic(TECX)
$20.98-0.16 (-0.76%)
TECX
Tectonic Therapeutic stock drug pipeline
$20.98
At close:-0.16 (-0.76%)
Want to see TECX full AI Analyst Report?
Tectonic Therapeutic (TECX) Drug Pipeline
673 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tx000045- Dose A, Tx000045- Dose B | Heart Failure With Preserved Ejection Fraction, Pulmonary Hypertension | Phase II | Recruiting | A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) | Sep 19, 2024 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tx000045- Dose A, Tx000045- Dose B | Phase II | Heart Failure With Preserved Ejection Fraction, Pulmonary Hypertension | Recruiting | A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) | Sep 19, 2024 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tectonic Therapeutic Inc (TECX) have in its pipeline
Tectonic Therapeutic TECX is currently developing the following drugs: Tx000045- Dose A, Tx000045- Dose B. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

